| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.087 | 0.3 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.3 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |